Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-132885
Filing Date
2025-06-02
Accepted
2025-06-02 09:20:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d944881ddefa14a.htm DEFA14A 29242
2 GRAPHIC g944881dsp004.jpg GRAPHIC 39855
  Complete submission text file 0001193125-25-132885.txt   85546
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19311 | Film No.: 251013304
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)